Citric Acid Metabolism in Resistant Hypertension
Ácido cítrico
Male
0301 basic medicine
Drug-Related Side Effects and Adverse Reactions
Drug Resistance
610
Spironolactone
Urinalysis
Citric Acid
03 medical and health sciences
Predictive Value of Tests
Hipertensión
Humans
Antihypertensive Agents
Sistema cardiovascular
Aged
Middle Aged
Prognosis
3. Good health
Spain
Hypertension
Ketoglutaric Acids
Female
Chromatography, Liquid
DOI:
10.1161/hypertensionaha.117.09819
Publication Date:
2017-09-06T00:40:35Z
AUTHORS (11)
ABSTRACT
Resistant hypertension (RH) affects 9% to 12% of hypertensive adults. Prolonged exposure suboptimal blood pressure control results in end-organ damage and cardiovascular risk. Spironolactone is the most effective drug for treatment, but not all patients respond side effects are negligible. Little known on mechanisms responsible RH. We aimed identify metabolic alterations urine. In addition, a potential capacity metabolites predict response spironolactone was investigated. Urine collected from 29 with RH group 13 subjects pseudo-RH. For patients, samples were before after administration classified responders (n=19) nonresponders (n=10). Nuclear magnetic resonance applied altered pathways. Metabolites confirmed by liquid chromatography-mass spectrometry. Citric acid cycle pathway significantly (P<0.0001). Metabolic concentrations quantified ranged ng/mL malate μg/mL citrate. Citrate oxaloacetate increased versus pseudoresistant. Together α-ketoglutarate malate, they able discriminate between nonresponders, being 4 nonresponders. Combined as prediction panel, showed receiver operating characteristiccurve area under curve 0.96. show that citric deregulation reactive oxygen species homeostasis continue its activation developed. A panel showing alteration treatment predicting future shown. These molecular indicators will contribute optimizing rate spironolactone.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (40)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....